Sign in
4

Changes in Ownership

Humacyte, Inc. Filed Acc 0001104659-23-065547

Chief Operating Officer sold 23,402 shares at an average $4.01 ($93,904)

  • Chief Operating Officer acquired 78,779 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Prichard Heather Ledbetter · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-24 Exercise or conversion : show line 1 in the form +13,789 $1.19 $16,409 22,978 D
2023-05-24 Sale : show line 2 in the form −13,789 $4.14 $57,086 9,189 D
2023-05-25 Exercise or conversion : show line 3 in the form +64,990 $1.19 $77,338 74,179 D
2023-05-25 Sale : show line 4 in the form −9,613 $3.83 $36,818 64,566 D
Open-market sales · 23,402 sh · avg $4.01 · $93,904

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-05-24 Exercise or conversion : show line 5 in the form Stock Options (right to buy) −13,789 64,990 D
2023-05-25 Exercise or conversion : show line 6 in the form Stock Options (right to buy) −64,990 0 D
Loading xslF345X04/tm2317123-10_4seq1.xml…